Literature DB >> 10334493

Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient.

S G van Duinen1, G J Lammers, M L Maat-Schieman, R A Roos.   

Abstract

Lewy bodies (LB) and pale bodies (PB), their putative precursors, can be found in a spectrum of diseases characterized by parkinsonism and/or dementia. Furthermore, LB are occasionally observed in some other neurodegenerative diseases and in normal aging. Classical LB are typically found in the brain stem, especially in the substantia nigra, where these inclusions are associated with neuronal loss and clinical signs of idiopathic Parkinson's disease (PD). The so-called cortical LB occur in the cerebral cortex, amygdala and claustrum with little or no neuronal loss and are clinically associated with dementia in dementia with LB (DLB). We describe a patient without apparent clinical signs of parkinsonism and/or dementia, whose brain contained numerous classical-like LB, pale inclusions with features of PB and transitions between these two. These inclusions had similar immunohistological (ubiquitin positive; neurofilament positive; tau negative) and ultrastructural features as the LB in PD and DLB except for the lack of immunoreactivity for alpha-synuclein. The pons and cerebral cortex showed the highest number of LB, up to 165/1.76 mm2. These numbers were contrasted by the lack of obvious neuronal loss or gliosis. The absence of alpha-synuclein reactivity in the LB in this symptomless patient corroborates the hypothesis that alpha-synuclein accumulation in LB is an important step in neurodegeneration in PD and DLB, but tones down the role of alpha-synuclein in LB formation in general. This patient seems to represent a new variant in the spectrum of diseases associated with LB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334493     DOI: 10.1007/s004010051025

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  3 in total

1.  Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.

Authors:  Polina Kokoulina; Troy T Rohn
Journal:  Neurodegener Dis       Date:  2010-05-05       Impact factor: 2.977

2.  Functionally different α-synuclein inclusions yield insight into Parkinson's disease pathology.

Authors:  Christian C Raiss; Theresa S Braun; Irene B M Konings; Heinrich Grabmayr; Gerco C Hassink; Arshdeep Sidhu; Joost le Feber; Andreas R Bausch; Casper Jansen; Vinod Subramaniam; Mireille M A E Claessens
Journal:  Sci Rep       Date:  2016-03-17       Impact factor: 4.379

Review 3.  Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.

Authors:  Jean-Christophe Rochet; Tiago Fleming Outeiro; Kelly A Conway; Tomas T Ding; Michael J Volles; Hilal A Lashuel; Robert M Bieganski; Susan L Lindquist; Peter T Lansbury
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 2.866

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.